SLC7A11 and cancer: In addition, ROS trigger p14ARF (a cancer suppressor), which subsequently reactivates P53 and inhibits Nrf2 to activate ferroptosis and allow the downregulation of SLC7A11 and xCT activity (Chen et al., 2017).